To test this hypothesis, we exposed human and murine bladder cancer lines to mCherry-labeled BCG in the absence of immune effectors and monitored lactate production, glycolytic enzyme expression, and the real-time extracellular acidification rate (ECAR). This evidence concerns the gene HK1 and urinary bladder carcinoma.